AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+10.19%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$101M
AUM Growth
+$101M
(+3.9%)
Cap. Flow
-$4.04M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
35
Closed
61
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$1.25M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$1.16M |
| 3 |
ADC Therapeutics
ADCT
|
$1.14M |
| 4 |
Novavax
NVAX
|
$1.08M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$1.07M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$12.8M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$2.1M |
| 3 |
Invesco S&P 500 Pure Value ETF
RPV
|
$2.08M |
| 4 |
Sanofi
SNY
|
$1.72M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$1.59M |
Sector Composition
| 1 | Healthcare | 56.8% |
| 2 | Real Estate | 15.08% |
| 3 | Financials | 8.32% |
| 4 | Energy | 6.75% |
| 5 | Industrials | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Aflac
AFL
$56.3B
| $284K | 0.28% |
+3,954
| New | +$284K |
|
102
Globe Life
GL
$11.2B
| $284K | 0.28% |
+2,358
| New | +$284K |
|
103
Johnson & Johnson
JNJ
$429B
| $282K | 0.28% |
+1,596
| New | +$282K |
|
104
UnitedHealth
UNH
$281B
| $281K | 0.28% |
530
+109
| +26% | +$57.8K |
|
105
McKesson
MCK
$86.1B
| $279K | 0.28% |
+743
| New | +$279K |
|
106
Progressive
PGR
$144B
| $278K | 0.28% |
+2,147
| New | +$278K |
|
107
Cencora
COR
$57.4B
| $278K | 0.27% |
1,678
+346
| +26% | +$57.3K |
|
108
W.R. Berkley
WRB
$27.2B
| $278K | 0.27% |
3,828
+784
| +26% | +$56.9K |
|
109
AbbVie
ABBV
$374B
| $274K | 0.27% |
1,693
+358
| +27% | +$57.9K |
|
110
Hewlett Packard
HPE
$29.5B
| $272K | 0.27% |
17,013
-287
| -2% | -$4.58K |
|
111
PepsiCo
PEP
$208B
| $270K | 0.27% |
1,496
+311
| +26% | +$56.2K |
|
112
Jack Henry & Associates
JKHY
$11.8B
| $269K | 0.27% |
+1,532
| New | +$269K |
|
113
D.R. Horton
DHI
$51B
| $267K | 0.26% |
3,000
| – | – |
|
114
Genuine Parts
GPC
$19.2B
| $267K | 0.26% |
+1,539
| New | +$267K |
|
115
Hershey
HSY
$37.6B
| $265K | 0.26% |
1,144
+237
| +26% | +$54.9K |
|
116
Imperial Oil
IMO
$45.6B
| $265K | 0.26% |
5,431
-26
| -0.5% | -$1.27K |
|
117
Chevron
CVX
$326B
| $263K | 0.26% |
+1,463
| New | +$263K |
|
118
Amgen
AMGN
$154B
| $261K | 0.26% |
+992
| New | +$261K |
|
119
Nucor
NUE
$33.7B
| $256K | 0.25% |
1,939
-1,798
| -48% | -$237K |
|
120
Kellanova
K
$27.5B
| $255K | 0.25% |
3,579
+752
| +27% | +$53.6K |
|
121
Bristol-Myers Squibb
BMY
$96.5B
| $253K | 0.25% |
+3,518
| New | +$253K |
|
122
Republic Services
RSG
$72.6B
| $253K | 0.25% |
1,961
+404
| +26% | +$52.1K |
|
123
Coca-Cola
KO
$296B
| $252K | 0.25% |
3,963
+828
| +26% | +$52.7K |
|
124
Nuveen Municipal High Income Opportunity Fund
NMZ
$1.16B
| $239K | 0.24% |
23,100
-900
| -4% | -$9.31K |
|
125
Nuveen Municipal Credit Opportunities Fund
NMCO
$566M
| $237K | 0.23% |
21,550
-1,000
| -4% | -$11K |
|